Home LiteratureArticle Details
PMID: 17510013 Published · ppublish English Journal Article

New drugs: paliperidone, dasatinib, and decitabine.

Journal of the American Pharmacists Association : JAPhA ·Vol. 47 ·No. 2 ·2007-00-00 ·Pages 298-302

Hussar DA

Abstract

暂无摘要

MeSH Terms
Antineoplastic Agents/adverse effects,pharmacokinetics,therapeutic use Antipsychotic Agents/adverse effects,pharmacokinetics,therapeutic use Azacitidine/adverse effects,analogs & derivatives,pharmacokinetics,therapeutic use Dasatinib Decitabine Humans Isoxazoles/adverse effects,pharmacokinetics,therapeutic use Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy Myelodysplastic Syndromes/drug therapy Paliperidone Palmitate Protein Kinase Inhibitors/adverse effects,pharmacokinetics,therapeutic use Pyrimidines/adverse effects,pharmacokinetics,therapeutic use Schizophrenia/drug therapy Thiazoles/adverse effects,pharmacokinetics,therapeutic use
Chemicals
Antineoplastic Agents Antipsychotic Agents Isoxazoles Protein Kinase Inhibitors Pyrimidines Thiazoles Decitabine Azacitidine Paliperidone Palmitate Dasatinib
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Hussar Daniel A
Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, Philadelphia, PA, USA.
Article Info
Journal
Journal of the American Pharmacists Association : JAPhA
Abbr.
J Am Pharm Assoc (2003)
ISSN
1544-3450
Published
2007-00-00
Pages
298-302
Language
English
Region
United States
NLM ID
101176252
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com